Asian Market Gems: Uncovering 3 Stocks Estimated Below Intrinsic Value

Simply Wall St

Amidst global concerns over AI valuations and fluctuating market sentiments, Asian markets have also experienced volatility, with notable declines in key indices like Japan's Nikkei 225 and China's CSI 300. In this environment of uncertainty, identifying stocks that are potentially undervalued can be an attractive strategy for investors seeking opportunities; these stocks may offer value by trading below their intrinsic worth despite broader market challenges.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

NameCurrent PriceFair Value (Est)Discount (Est)
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)CN¥16.85CN¥32.5048.1%
Xi'an NovaStar Tech (SZSE:301589)CN¥155.90CN¥305.6249%
TLB (KOSDAQ:A356860)₩62400.00₩120421.2048.2%
SRE Holdings (TSE:2980)¥3120.00¥6130.7249.1%
Samyang Foods (KOSE:A003230)₩1380000.00₩2799114.4650.7%
Raksul (TSE:4384)¥1148.00¥2276.9149.6%
Nippon Thompson (TSE:6480)¥706.00¥1407.3549.8%
Nanjing COSMOS Chemical (SZSE:300856)CN¥15.12CN¥29.4448.6%
IDEC (TSE:6652)¥2566.00¥4975.5948.4%
Cowell e Holdings (SEHK:1415)HK$26.42HK$51.8549%

Click here to see the full list of 276 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Zhejiang Cfmoto PowerLtd (SHSE:603129)

Overview: Zhejiang Cfmoto Power Co., Ltd, with a market cap of CN¥37.85 billion, develops, manufactures, markets, and delivers motorcycles, off-road vehicles, engines, frames, parts, apparel, and accessories across various global regions including China.

Operations: Zhejiang Cfmoto Power Co., Ltd generates revenue through its diverse operations in the development, production, and distribution of motorcycles, off-road vehicles, engines, frames, parts, apparel, and accessories across China and international markets such as Asia, North America, Oceania, Africa, South America, and Europe.

Estimated Discount To Fair Value: 37.2%

Zhejiang Cfmoto Power Ltd. appears undervalued based on cash flows, trading at approximately 37.2% below its estimated fair value of CNY 395.18. Recent earnings results show strong performance with sales reaching CNY 14.90 billion and net income of CNY 1.42 billion for the nine months ending September 2025, reflecting robust growth from the previous year. The company's revenue and earnings are forecast to grow significantly, outpacing market averages, highlighting its potential as an investment opportunity in Asia's undervalued stock segment.

SHSE:603129 Discounted Cash Flow as at Nov 2025

Lifedrink Company (TSE:2585)

Overview: Lifedrink Company, Inc. manufactures and sells soft drinks in Japan with a market cap of ¥111.66 billion.

Operations: Revenue Segments (in millions of ¥): The company's revenue is derived from the manufacturing and sale of soft drinks in Japan.

Estimated Discount To Fair Value: 17.1%

Lifedrink Company is trading at ¥2,153, below its estimated fair value of ¥2,596.81, suggesting it may be undervalued based on cash flows. Earnings are projected to grow at 14.9% annually, surpassing the JP market average of 8.1%. Despite a high debt level and volatile share price recently, Lifedrink's buyback program aims to enhance shareholder returns and capital efficiency by repurchasing shares worth ¥491.87 million as of September 2025.

TSE:2585 Discounted Cash Flow as at Nov 2025

Sawai Group Holdings (TSE:4887)

Overview: Sawai Group Holdings Co., Ltd. operates in the research, development, manufacture, and marketing of generic pharmaceuticals and has a market capitalization of approximately ¥219.83 billion.

Operations: The company generates revenue through its involvement in the research, development, production, and distribution of generic pharmaceuticals.

Estimated Discount To Fair Value: 45.6%

Sawai Group Holdings is trading at ¥1,903.5, significantly below its estimated fair value of ¥3,497.48, indicating potential undervaluation based on cash flows. Despite a forecasted annual earnings growth of 27.64%, the company faces challenges such as lower profit margins and a dividend not well covered by earnings or free cash flows. Recent legal settlements have impacted financial forecasts, with revised guidance showing reduced operating profits and revenue for the fiscal year ending March 2026.

TSE:4887 Discounted Cash Flow as at Nov 2025

Where To Now?

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Sawai Group Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com